Congressional Stock Trades & Disclosures
Keith Self is a U.S. Representative, a Republican representing TX. As of October 2025, Quantellect has tracked 11 disclosed stock trades across 6 companies, representing $88.01K in disclosed transaction value, each filed publicly under the STOCK Act.
About Keith Self's congressional trading
Across the disclosures Quantellect has on file for 2025, U.S. Representative Keith Self's household reported 11 securities transactions, and all but one of them are attributed to his spouse. The single transaction attributed to Self personally, a sale of Leidos Holdings stock in October 2025, stands apart both in attribution and in timing: it is the most recent disclosed trade in the record and the only one not filed under spousal attribution. The other 10 transactions share a January 10, 2025 transaction date and were disclosed in two batches filed on January 23, 2025 and June 30, 2026.
That split-filing pattern is itself the most notable feature of Self's disclosure history so far. A first set of January 10 transactions was reported on January 23, 2025. A second set carrying the identical January 10, 2025 transaction date was disclosed on June 30, 2026. The record therefore keeps two different dates in view: when each transaction was reported as occurring and when the corresponding filing became public. Across the supplied record, all 11 transaction dates fall in 2025, with 10 on January 10 and the Leidos sale on October 7.
What Has Been Disclosed and by Whom
Of the 11 transactions, 7 are purchases and 4 are sales. Ten of the 11 carry the "Spouse" attribution code, meaning the record reports the transactions under Self's spouse rather than under the congressman himself. Only the Leidos sale is coded "Self." Those attribution fields identify the person associated with each reported transaction and do not support attributing the spouse-coded trades to Self personally.
The most frequently disclosed securities in this record are Merck & Company (MRK), which appears twice, once as a purchase and once as a sale, and NVIDIA Corporation (NVDA), which appears twice, both as purchases. Genuine Parts Co (GPC) and PepsiCo (PEP) each appear once, both as purchases, and Leidos Holdings (LDOS) appears once, as the sale attributed to Self himself. Quantellect's record matches each of these five names with a ticker, company identity, sector, and industry.
Four additional entries in the record could not be matched to a ticker or company record: two separate sales listed as "AT&T Inc" and "ATT (INC)," a purchase listed as "Greuhke Parts Co," and a purchase listed as "Pepsieo (INC)." These labels are reproduced from the transaction record. The available data does not confirm their sector, industry, or corporate identity, so this profile does not assign them one.
Sectors and the Companies Behind the Tickers
Among the transactions with a confirmed sector, Health Care and Information Technology each account for two. Consumer Discretionary, Consumer Staples, and Industrials each account for one transaction. The four unmatched entries are recorded separately and are not assigned to any of those sectors.
Merck is a global healthcare company whose business spans human pharmaceuticals, vaccines, and animal health, with products including Keytruda, Gardasil, and Bravecto and collaborations with partners including Daiichi Sankyo, AstraZeneca, and Moderna. NVIDIA provides data-center accelerated computing, AI infrastructure, networking, and graphics products through its Compute & Networking and Graphics segments, selling to cloud providers, automakers, device manufacturers, and other customers worldwide. Genuine Parts Company distributes automotive and industrial replacement parts, including through the NAPA brand, and serves independent repair shops, auto care centers, and industrial customers. PepsiCo manufactures, markets, distributes, and sells beverages and convenient foods worldwide across six operating segments, serving retailers, distributors, food-service customers, and consumers. Leidos Holdings, the subject of the one self-attributed sale, provides technology and services to government and commercial customers in the United States and internationally, including national security software, health IT, air traffic control systems, aviation and border-security screening equipment, and defense systems.
Each disclosed amount range in this record falls between $1,001 and $15,000 across every transaction, regardless of ticker or attribution. No score is available for Self at Quantellect's latest published score date of August 21, 2026; the record states that no score row exists for him on that date. Quantellect had scores for 76 members overall, including 73 sitting members. As measured on August 22, 2026, of the 537 sitting members Quantellect tracks, 276 have no disclosed transactions, including 237 of the 437 sitting House members. Self's 11 disclosed transactions place him among the House members with reported transaction activity.
Disclosure and Methodology
This profile is built from congressional Periodic Transaction Reports filed under the Stop Trading on Congressional Knowledge Act of 2012 and instructions published in the House Committee on Ethics financial disclosure instruction guide. Underlying filings referenced in this profile include reports filed on January 23, 2025, October 14, 2025, and June 30, 2026. Transactions carrying a "Spouse" attribution are reported for the member's spouse, not the member personally, and dollar figures reflect disclosed ranges rather than exact transaction amounts. Throughout this profile, transaction dates identify when trades were reported as occurring, while disclosure dates identify when the corresponding filings were made public.
Trading activity
Estimated trading profits
No priced buy disclosures in this window.
Based on 5 of 5 disclosed buys with pricing coverage.
Aug 26, 2025 to Aug 25, 2026
Based on 5 of 7 disclosed buys with pricing coverage.
Jan 10, 2025 to Aug 25, 2026
Estimated unrealized profit is based on disclosed buy transactions, estimated trade price, and the latest priced-through date. It does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. This is descriptive research, not investment advice, and not an allegation of wrongdoing.
Where the Money Sits
share of disclosed trades · top sectors
Periodic Transaction Report filings
| Company | Type | Size | Traded | Est. price | Change |
|---|---|---|---|---|---|
LDOSLeidos Holdings Inc | Sell | $1,001 - $15,000 | 07 OCT 2025 | $196.07 | -31.38% |
NVDANVIDIA Corporation | Buy | $1,001 - $15,000 | 10 JAN 2025 | $135.87 | +56.81% |
AT&T Inc | Sell | $1,001 - $15,000 | 10 JAN 2025 | — | — |
PEPPepsiCo Inc | Buy | $1,001 - $15,000 | 10 JAN 2025 | $135.94 | +4.65% |
GPCGenuine Parts Co | Buy | $1,001 - $15,000 | 10 JAN 2025 | $111.28 | +23.97% |
MRKMerck & Company Inc | Sell | $1,001 - $15,000 | 10 JAN 2025 | $94.95 | +64.77% |
MRKMerck & Company Inc | Buy | $1,001 - $15,000 | 10 JAN 2025 | $94.95 | +64.77% |
Pepsieo (INC) | Buy | $1,001 - $15,000 | 10 JAN 2025 | — | — |
Greuhke Parts Co | Buy | $1,001 - $15,000 | 10 JAN 2025 | — | — |
NVDANVIDIA Corporation | Buy | $1,001 - $15,000 | 10 JAN 2025 | $135.87 | +56.81% |
Congressional trading news
The latest news on congressional stock trading, across all members, will appear here as our newsroom publishes it.
Keith Self congressional trading FAQ
Can Keith Self legally trade stocks?
Yes. Members of Congress are permitted to buy and sell stocks, but the 2012 STOCK Act requires them to publicly disclose each transaction, generally within 45 days. Quantellect compiles Keith Self's disclosures so the public can review them.
Where does Quantellect get Keith Self's trading data?
Every trade shown is sourced from official Periodic Transaction Reports filed under the STOCK Act. Amounts are reported as ranges, and estimated prices and post-trade returns are derived from end-of-day market data.
How can I track Keith Self's stock trades?
Quantellect tracks every stock trade Keith Self discloses under the STOCK Act on this page, including the company, the disclosed amount range, and post-trade performance. New filings appear here as they are reported, generally within 45 days of the trade.
How many stock trades has Keith Self disclosed?
Quantellect has tracked 11 disclosed trades by Keith Self across 6 companies.
Which stocks does Keith Self trade most?
Keith Self's most frequently disclosed positions are MRK (2 disclosed trades), NVDA (2 disclosed trades), GPC (1 disclosed trade), LDOS (1 disclosed trade), and PEP (1 disclosed trade). The full list of companies and individual filings is shown on this page.
Which sectors does Keith Self invest in?
Technology is the heaviest sector in Keith Self's classified disclosures, covering 3 disclosed trades. The full sector breakdown is shown on this page and is derived from the companies behind each disclosed transaction.
What was Keith Self's most recent stock trade?
Keith Self most recently sold Leidos Holdings Inc (LDOS) in October 2025, according to public STOCK Act filings tracked by Quantellect.
What is Keith Self's Quantellect Score?
Keith Self has a Quantellect Score of 55 out of 100 (Solid). The score ranks members by the estimated unrealized results of their disclosed buys over the last 24 months, weighting estimated total profit, profit versus the S&P 500, and win rate. It is a descriptive research signal, not investment advice or an allegation of unlawful trading.
How much has Keith Self made trading stocks?
Quantellect estimates Keith Self's disclosed buys show an estimated unrealized profit of $15,193 over the trailing 12 months, based on priced disclosed buy transactions through August 25, 2026. This is an estimate and does not account for later sales, taxes, commissions, slippage, exact execution price, or full portfolio position size. It is descriptive research, not investment advice or an allegation of wrongdoing.
Browse all members of Congress who trade stocksSee which stocks Congress tradesCongressional trading overview
Trades reflect disclosures filed under the STOCK Act and are provided for informational purposes only, not investment advice. Amounts are ranges from official filings; estimated prices and post-trade returns are derived from end-of-day market data and may be revised as filings are amended.






